Substance abuse treatment for women: Changes in the settings where women received treatment and types of services provided, 1987-1998

Journal of Behavioral Health Services and Research

Volumn 31, Issue 4, 2004, Pages 367-383

  Grella, Christine E ^a   Greenwell, Lisa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD CARE; CHILD PARENT RELATION; DATA ANALYSIS; DOMESTIC VIOLENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; PREGNANCY; TIME SERIES ANALYSIS;

EID: 7044239649     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02287690     Document Type: Article

References (85)

1. Reed BG. Developing women-sensitive drug dependence treatment services: why so difficult? Journal of Psychoactive Drugs. 1987;19(2):151-164.
2. Kandel DB. Gender differences in the epidemiology of substance dependence in the United States. In: Frank E, ed. Gender and its Effects on Psychopathology. Washington, DC: American Psychiatric Press; 2000:231-252.
3. Mahan S. Crack, Cocaine, Crime, and Women: Legal, Social, and Treatment Issues. Thousand Oaks, Calif: Sage; 1996.
4. Breitbart V, Chavkin W, Wise PH. The accessibility of drug treatment for pregnant women: a survey of programs in five cities. American Journal of Public Health. 1994;84(10):1658-1661.
5. Schmidt L, Weisner C. The emergence of problem-drinking women as a special population in need of treatment. In: Galanter M. ed. Recent Developments in Alcoholism: Alcoholism and Women. New York: Plenum; 1995:309-334.
6. Chavkin W, Breitbart V, Elman D, et al. National survey of the states: policies and practices regarding drug-using pregnant women. American Journal of Public Health. 1998;88(1):117-119.
7. General Accounting Office. Drug Exposed Infants. A Generation at Risk. Washington, DC: Government Printing Office; 1990. Report No. (GAO/HRD)90-138.
8. Center for Substance Abuse Treatment. Telling Their Stories: Reflections of the 11 Original Grantees That Piloted Residential Treatment for Women and Children for CSAT. Rockville, Md: Center for Substance Abuse Treatment, Substance Abuse & Mental Health Services Administration; 2001. SAMHSA Publication No. (SMA)01-3529).
9. Eisen M, Keyser-Smith J, Dampeer J, et al. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment. Addictive Behavior. 2000;25(1):123-129.
10. Nunes-Dinis M. Drug and alcohol misuse: treatment outcomes and services for women. In: Barth RP, Pietrzak P, Ramler M, eds. Families Living With Drugs and HIV: Intervention & Treatment. New York: Guilford Press; 1993:144-176.
11. Rahdert ER, ed. Treatment for Drug-exposed Women and Their Children: Advances in Research Methodology. Rockville, Md: US Dept Health & Human Services, National Institutes of Health; 1996. NIDA Research Monograph, No. 165.
12. Blumenthal SJ. Women and substance abuse: a new national focus. In: Wetherington CL, Roman AB, eds. Drug Addiction Research and the Health of Women. Rockville, Md: US Dept of Health & Human Services, National Institutes of Health, National Institute on Drug Abuse; 1998:197-222.
13. Kissin WB, Svikis DS, Morgan GD, et al. Characterizing pregnant drug-dependent women in treatment and their children. Journal of Substance Abuse Treatment. 2001;21:27-34.
14. Haller DL, Knisely JS, Dawson KS, et al. Perinatal substance abusers: psychological and social characteristics. Journal of Nervous and Mental Disease. 1993;181:509-513.
15. Comfort M, Kaltenbach KA. Predictors of treatment outcomes for substance abusing women: a retrospective study. Substance Abuse. 2000;21(1):33-45.
16. Howell EM, Chasnoff IJ. Perinatal substance abuse treatment: findings from focus groups with clients and providers. Journal of Substance Abuse Treatment. 1999;17:139-148.
17. Brown VB, Sanchez S, Zweben JE, et al. Challenges in moving from a traditional therapeutic community to a women and children's TC model. Journal of Psychoactive Drugs. 1996;28(1):39-46.
18. Hodgins DC, el-Guebaly N, Addington J. Treatment of substance abusers: single or mixed gender programs? Addiction. 1997;92(7):805-812.
19. Stevens SJ, Arbiter N. A therapeutic community for substance-abusing pregnant women and women with children: process and outcome. Journal of Psychoactive Drugs. 1995;27(1):49-56.
20. Dahlgren L, Willander A. Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcoholism: Clinical and Experimental Research. 1989;13(4):499-504.
21. Jessup MA, Humphreys JC, Brindis CD, et al. Extrinsic barriers to substance abuse treatment among pregnant drug dependent women. Journal of Drug Issues. 2003;33(2):285-304.
22. Luthar SS, Walsh KG. Treatment needs of drug-addicted mothers: integrated parenting psychotherapy interventions. Journal of Substance Abuse Treatment. 1995;12;341-348.
23. Bloom B, Owen B, Covington S. Gender-responsive strategies: Research, Practice, and Guiding Principles for Women Offenders. Washington, DC: National Institute of Corrections, US Dept of Justice; 2003.
24. Grella CE, Polinsky M, Hser YI, et al. Characteristics of women-only and mixed-gender drug abuse treatment programs. Journal of Substance Abuse Treatment. 1999;17(1/2):37-44.
25. Uziel-Miller ND, Lyons SS. Specialized substance treatment for women and their children: an analysis of program design. Journal of Substance Abuse Treatment. 2000;19:355-367.
26. Copeland J, Hall W, Didcott P, et al. A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: client characteristics and treatment outcome. Drug and Alcohol Dependence. 1993;32(1):81-92.
27. Reed BG, Leibson E. Women clients in special women's demonstration drug abuse treatment programs compared with women entering selected co-sex programs. International Journal of the Addictions. 1981;16(8):1425-1466.
28. Grella CE. Women in residential drug treatment: differences by program type and pregnancy. Journal of Health Care for the Poor & Underserved. 1999;10(2):216-229.
29. Grella CE, Joshi V, Hser YI. Program variation in treatment outcomes among women in residential drug treatment. Evaluation Review. 2000;24(4):364-383.
30. Szuster RR, Rich LL, Chung A, et al. Treatment retention in women's residential chemical dependency treatment: the effect of admission with children. Substance Use & Misuse. 1996;31:1001-1013.
31. Hughes PH, Coletti SD, Neri RL, et al. Retaining cocaine abusing women in a therapeutic community: the effect of a child live-in program. American Journal of Public Health. 1995;85:1149-1152.
32. Stevens SJ, Patton T. Residential treatment for drug addicted women and their children: effective treatment strategies. Drugs & Society. 1998;13(1/2):235-249.
33. Wobie K, Eyler FD, Conlon M, et al. Women and children in residential treatment: outcomes for mothers and their infants. Journal of Drug Issues. 1997;27(3):585-606.
34. Zlotnick C, Franchino K, St Claire N, et al. The impact of outpatient drug services on abstinence among pregnant and parenting women. Journal of Substance Abuse Treatment. 1996;13(3):195-202.
35. Volpicelli JR, Markman I, Monterosso J, et al. Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy. Journal of Substance Abuse Treatment. 2000;18(1):41-49.
36. Wingfield K, Klempner T. What works in women-oriented treatment for substance abusing mothers. In: Kluger MP, Alexander G, eds. What Works in Child Welfare. Washington, DC: Child Welfare League of America Inc; 2000:113-124.
37. Brindis CD, Berkowitz G, Clayson Z, et al. California's approach to perinatal substance abuse: toward a model of comprehensive care. Journal of Psychoactive Drugs. 1997;29(1):113-122.
38. Howell EM, Heiser N, Harrington M. A review of recent findings on substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment. 1999;16(3):195-219.
39. Lanehart RE, Clark HB, Rollings JP, et al. The impact of intensive case-managed intervention on substance-using pregnant and postpartum women. Journal of Substance Abuse. 1996;8(4):487-495.
40. Strantz IH, Welch SP. Postpartum women in outpatient drug abuse treatment: correlates of retention/completion. Journal of Psychoactive Drugs. 1995;27(4):357-373.
41. Weisdorf T, Parran TV, Graham A, et al. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine-addicted pregnant women. Journal of Substance Abuse Treatment. 1999;16:39-45.
42. Camp JM, Finkelstein N. Parenting training for women in residential substance abuse treatment: results of a demonstration project. Journal of Substance Abuse Treatment. 1997;14(5):411-422.
43. Sanders LM, Trinh C, Sherman BR. Assessment of client satisfaction in a peer counseling substance abuse treatment program for pregnant and postpartum women. Evaluation and Program Planning. 1998;21:287-296.
44. Smith BD, Marsh JC. Client-service matching in substance abuse treatment for women with children. Journal of Substance Abuse Treatment. 2002;22(3):161-168.
45. Marsh JC, D'Aunno TA, Smith BD. Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction. 2000;95(8):1237-1247.
46. Orwin R, Francisco L, Bernichon T. Effectiveness of Women's Substance Abuse Treatment Programs: A Meta-analysis. Fairfax, Va: Caliber Associates; 2001. NEDS Analytic Summary Series No 21.
47. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. American Journal of Drug and Alcohol Abuse. 2003;29(1):19-53.
48. General Accounting Office. ADMS Block Grant: Women's Set-aside Does Not Assure Drug Treatment for Pregnant Women. Washington, DC: US General Accounting Office; 1991. Report No. (GAO-T-HRD)91-37.
49. Chavkin W, Breitbart V Substance abuse and maternity: the United States as a case study. Addiction. 1997;92(9):1201-1205.
50. Chavkin W, Wise P, Elman D. Policies towards pregnancy and addiction: sticks without carrots. In: Harvey JA, Kosofsky BE, eds. Cocaine: Effects on the Developing Brain. New York: New York Academy of Sciences; 1998:335-340.
51. Drug Strategies. Keeping Score. Women and Drugs: Looking at the Federal Drug Control Budget. Washington. DC: Drug Strategies; 1998.
52. Shepard DS, Larson MJ, Hoffmann NG. Cost-effectiveness of substance abuse services: implications for public policy. Psychiatric Clinics of North America. 1999;22(2):385-400.
53. Weisner C, McCarty D, Schmidt L. New directions in alcohol and drug treatment under managed care. American Journal of Managed Care. 1999;5:57-69.
54. Blanch AK, Levin BL. Organization and services delivery. In: Levin BL, Blanch AK, Jennings A, eds. Women's Mental Health Services: A Public Health Perspective. Thousand Oaks, Calif: Sage; 1998:5-18.
55. Schreter RK. Ten trends in managed care and their impact on the biopsychosocial model. Hospital & Community Psychiatry. 1993;44(4):325-327.
56. Reed BG, Mowbray CT. Mental illness and substance abuse: implications for women's health and health care access. Journal of American Medical Women's Association. 1999;54(2):71-78.
57. Bloom B, Owen B, Covington S. Women offenders and the gendered effects of public policy. Review of Policy Research. 2004;21(1):31-48.
58. Marquart JW, Brewer VE, Mullings J, et al. The implications of crime control policy on HIV/AIDS-related risk among women prisoners. Crime & Delinquency. 1999;45(1):82-98.
59. Bureau of Justice Statistics. Prison statistics, summary findings on December 31, 2002. 2002. Available at: http://www.ojp.us-doj.gov/bjs/prisons. htm/. Accessed February 5, 2004.
60. Mauer M, Potler C, Wolf R. Gender and Justice: Women, Drugs, and Sentencing Policy. Washington, DC: The Sentencing Project; 1999.
61. General Accounting Office. Women in Prison: Issues and Challenges Confronting US Correctional Systems. Washington DC: Government Printing Office; 1999. Report No. (GAO/GGD)00 22.
62. Jordan BK, Federman EB, Burns, BJ, et al. Lifetime use of mental health and substance abuse treatment services by incarcerated women felons. Psychiatric Services. 2002;53(3):317-325.
63. Teplin LA, Abram KM, McClelland GM. prevalence of psychiatric disorders among incarcerated women: pretrial jail detainees. Archives of General Psychiatry. 1996;53(6):505-512.
64. Office of Applied Studies. Uniform Facility Data Set (UFDS): 1998. Data on Substance Abuse Treatment Facilities. Rockville, Md: Department of Health & Human Services, Substance Abuse & Mental Health Services Administration: 2000.
65. Etheridge RM, Hubbard RL, Anderson J, et al. Treatment structure and program services in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors. 1997;11(4):244-260.
66. Gerstein DR, Harwood HJ, eds. Treating Drug Problems. Vol 1. Washington, DC: National Academy Press; 1990.
67. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. The DASIS Report: Women in Substance Abuse Treatment. Rockville, Md: US Dept of Health & Human Services; 2001.
68. Office of Applied Studies. Uniform Facility Data Set (UFDS): Data for 1996 and 1980-1996. Rockville, Md: Dept of Health & Human Services, Substance Abuse & Mental Health Services Administration; 1997.
69. Svikis DS, Golden AS, Huggins GR, et al. Cost-effectiveness of treatment for drug-abusing pregnant women. Drug and Alcohol Dependence. 1997;45:105-113.
70. Daley M, Argeriou M, McCarty D, et al. The costs of crime and the benefits of substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment. 2000; 19:445-458.
71. French MT, McCollister KE, Cacciola J, et al. Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women. Substance Abuse. 2002;23(1):31-51.
72. Clark HW. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications. Child Welfare. 2001;80(2):179-198.
73. Mumola CJ. Substance Abuse and Treatment, State and Federal Prisoners, 1997. Washington, DC: US Dept of Justice, Office of Justice Programs; 1999. Bureau of Justice Statistics Special Report No. (NCJ)172871.
74. Prendergast ML, Wellisch J, Wong MM. Residential treatment for women parolees following prison based drug treatment: treatment experiences, needs and services, outcomes. The Prison Journal. 1996;76(3):253-274.
75. Prendergast ML, Wellisch J, Falkin GP. Assessment of and services for substance abusing women offenders in community and correctional settings. The Prison Journal. 1995;75:240-256.
76. Alemagno SA. Women in jail: is substance abuse treatment enough? American Journal of Public Health. 2001;91(5):798-800.
77. Haywood TW, Kravitz HM, Goldman LB, et al. Characteristics of women in jail and treatment orientations: a review. Behavior Modification. 2000;24(3):307-324.
78. Koons BA, Burrow JD, Morash M, et al. Expert and offender perceptions of program elements linked to successful outcomes for incarcerated women. Crime & Delinquency. 1997;43(4):512-532.
79. Reed BG, Leavitt ME. Modified wraparound and women offenders in community corrections: strategies, opportunities, and tensions. In: McMahon M, ed. Assessment to Assistance: Programs for Women in Community Corrections. Lanham, Md: American Correctional Association; 2000:1-106.
80. Hall EA, Baldwin DM, Prendergast ML. Women on parole: barriers to success after substance abuse treatment. Human Organization. 2001;60(3):225-233.
81. Sandmaier M. The Invisible Alcoholics: Women and Alcohol Abuse in America. New York: McGraw-Hill; 1980.
82. Blume SB. Women and alcohol. Journal of the American Medical Association. 1986;256:1467-1469.
83. Beckman LJ, Kocel KM. The treatment-delivery system and alcohol abuse in women: social policy implications. Journal of Social Issues. 1982;38(2):139-151.
84. Office of Applied Studies. The DASIS Report: Pregnant Women in Substance Abuse Treatment. Rockville, Md: US Dept of Health & Human Services, Substance Abuse & Mental Health Services Administration; 2002.
85. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public's demand for quality care? Journal of Substance Abuse Treatment. 2003;25:117-121.